Angiogenesis, Metastasis, and the Cellular Microenvironment
Imatinib Mesylate (STI-571) Reduces Bcr-Abl-Mediated Vascular Endothelial Growth Factor Secretion in Chronic Myelogenous Leukemia1
1
Studentships from the Canadian Institute for Health Research (CIHR) and National Cancer Institute of Canada (NCIC) (to Z.M. and J.T, respectively); CIHR (to R.S.K.).
John M.L. Ebos, Jennifer Tran, Zubin Master, Daniel Dumont, Junia V. Melo, Elisabeth Buchdunger and Robert S. Kerbel
Mol Cancer Res December 1 2002 1 (2) 89-95;